FDA Inspection 1149010 - HomeChoice Partners dba BioScript Infusion Services - August 09, 2021
FDA Inspection 1149010 for HomeChoice Partners dba BioScript Infusion Services on August 09, 2021. Classification: Voluntary Action Indicated (VAI).
One-time purchase from the GKS catalog. Lifetime access in your library. Single documents and full company profiles available. All sales final.
FDA Inspection 1149010 for HomeChoice Partners dba BioScript Infusion Services on August 09, 2021. Classification: Voluntary Action Indicated (VAI).
Access our comprehensive regulatory intelligence platform to analyze patterns, track compliance trends, and stay ahead of regulatory changes.
Inspection Date
August 9, 2021
Product Type
Drugs
ID: 46c0708b-268c-4a42-b981-2410f5dbb266
View on DashboardTransform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.
Try KeyPedia Today
Explore our real use cases and discover our features in depth.
Subscribe to our newsletter
Get the latest updates and insights delivered to your inbox